Corient Capital Partners, LLC Biogen Inc. Transaction History

Corient Capital Partners, LLC

$1.34 Billion
Q3 2022

A detailed history of Corient Capital Partners, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Corient Capital Partners, LLC holds 2,411 shares of BIIB stock, worth $486,539. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,411

Previous 1,959 23.07%

Holding current value

$486,539

Previous $400,000 23.0%

% of portfolio

0.04%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $87,999 - $121,343	452 Added 23.07%	2,411 $492,000
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $73,328 - $87,200	-391 Reduced 16.64%	1,959 $400,000
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $114,905 - $144,775	593 Added 33.75%	2,350 $495,000
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $173,761 - $223,309	-776 Reduced 30.64%	1,757 $421,000
Q3 2021 Nov 16, 2021	SELL	$282.99 - $369.05 $116,308 - $151,679	-411 Reduced 13.96%	2,533 $717,000
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $65,786 - $105,336	254 Added 9.44%	2,944 $1.02 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $87,462 - $102,466	360 Added 15.45%	2,690 $753,000
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $330,055 - $496,815	-1,397 Reduced 37.48%	2,330 $570,000
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $15,356 - $17,731	-58 Reduced 1.53%	3,727 $1.06 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $230,983 - $305,897	893 Added 30.88%	3,785 $1.01 Million
Q1 2020 May 06, 2020	BUY	$268.85 - $341.04 $47,317 - $60,023	176 Added 6.48%	2,892 $915,000
Q4 2019 Feb 04, 2020	SELL	$220.06 - $304.07 $580,298 - $801,832	-2,637 Reduced 49.26%	2,716 $806,000
Q3 2019 Nov 06, 2019	BUY	$217.44 - $243.88 $732,120 - $821,143	3,367 Added 169.54%	5,353 $1.25 Million
Q2 2019 Aug 08, 2019	BUY	$219.29 - $241.72 $137,275 - $151,316	626 Added 46.03%	1,986 $465,000
Q1 2019 May 10, 2019	BUY	$216.71 - $338.96 $33,156 - $51,860	153 Added 12.68%	1,360 $321,000
Q4 2018 Feb 07, 2019	BUY	$278.5 - $352.75 $117,527 - $148,860	422 Added 53.76%	1,207 $363,000
Q2 2018 Oct 02, 2018	BUY	$257.52 - $306.91 $202,153 - $240,924	785 New	785 $228,000
Q3 2017 Nov 14, 2017	SELL	$281.15 - $329.69 $262,875 - $308,260	-935 Closed	0 $0
Q2 2017 Aug 14, 2017	SELL	N/A	-52 Reduced 5.27%	935 $254,000
Q1 2017 Aug 17, 2017	SELL	N/A	-6,679 Reduced 87.12%	987 $270,000
Q1 2017 Aug 14, 2017	BUY	N/A	7,666	7,666 $835,000

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $29.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Account

Corient Capital Partners, LLC Biogen Inc. Transaction History